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ABSTRACT
Copper serves as a limiting factor for multiple steps of tumour 
progression, including angiogenesis, growth and metastasis. High 
levels of copper have been found in a wide spectrum of human 
cancers. Antitumour activities of copper-chelating drugs have 
been reported in animal models. Organosulfur compounds (di-
allyl sulfi de, DAS; diallyl disulfi de, DADS; S-ethylcysteine, SEC; 
N-acetylcysteine, NAC) derived from garlic exhibit marked cop-
per-chelating activity. We analysed a mixture of fi fteen n-propyl 
polysulfi des (DPPS) for potential antitumour activity against sev-
eral murine tumour cell lines, including colon carcinoma (CT26), 
mammary carcinoma (4T1) and melanoma cell lines (B16F10), 
and compared the eff ects with the antiproliferative eff ect in high-
ly proliferative murine mesenchymal stem cells (mMSCs). Th e 
eff ects of the mixture of n-propyl polysulfi des (100%) on cell vi-
ability were determined using MTT assays. Cell apoptosis was 
analysed using Annexin V-FITC/PI assays.
Th e results of the MTT assays indicate that this standard-
ized mixture of n-propyl polysulfi des has a strong, dose-depend-
ent cytotoxic eff ect against all three of the tested tumour cell 
lines (CT26, 4T1, B16F10). Th e cytotoxic eff ect of the n-propyl 
polysulfi de mixture against the CT26 and B16F10 cell lines was 
much stronger than that of cisplatin and was signifi cantly weak-
er in mMSCs, which are non-cancerous and highly proliferative 
cells, than in cancer cells. Flow cytometric analysis of CT26 and 
4T1 cells revealed that apoptosis was not the dominant mecha-
nism of cell death induced by the n-propyl polysulfi de mixture. 
Th e n-propyl polysulfi de mixture exerted highly cytotoxic activ-
ity against murine colon carcinoma and melanoma cell lines, 
but its antiproliferative activity against mMSCs was signifi cant-
ly lower than that of cisplatin. 
Keywords: n-propyl polysulfi des, tumour cell lines, cy-
totoxicity, in vitro
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 SAŽETAK
Bakar učestvuje u različitim fazama progresije tumora, 
u angiogenezi, rastu i metastaziranju. Povećane vrednosti 
bakra u serumu i u tkivu tumora, karakteristika su različi-
tih vrsta tumora kod ljudi. U animalnim eksperimentalnim 
modelima, supstance (lekovi) koje heliraju bakar ispoljavaju 
anti-tumorski efekat. Helatori bakra su i organosumporna 
jedinjenja, izolovana iz belog luka. U ovoj studiji analizirali 
smo potencijalnu anti-tumorsku aktivnost smeše petnaest 
različitih n-propil polisulfi da na nekoliko mišjih ćelijskih li-
nija tumora: karcinom kolona (CT26), karcinom dojke (4T1) 
i melanom (B16F10). Aktivnost ove smeše na tumorskim li-
nijama, uporedili smo sa antiproliferativnim efektom na me-
zenhimalne matične ćelije miša (engl. murine mesenchymal 
stem cells, mMSC). Efekat smeše n-propil polisulfi da (100%) 
na vijabilnost ćelija ispitali smo MTT testom. Apoptozu ćeli-
ja smo analizirali koristeći Annexin V-FITC/PI test.
Rezultati MTT testa ukazuju da standardizovana sme-
ša n-propil polisulfi da ima jak citotoksični, dozno-zavi-
sni, efekat na sve tri testirane ćelijske linije tumora (CT26, 
4T1, B16F10). Smeša n-propil polisulfi da ispoljava izraže-
niji citotoksični efekat na CT26 i B16F10 linije u odnosu 
na cisplatinu. Citotoksični efekat ove smeše na mMSC je 
značajno slabiji poredeći sa efektom cisplatine, što ukazu-
je na selektivnije dejstvo. Analiza CT26 i 4T1 ćelija pro-
točnom citometrijom pokazala je da apoptoza nije glavni 
oblik smrti ćelija, koju uzrokuje smeša n-propil polisulfi -
da. Smeša n-propil polisulfi da ispoljava jaču citotoksičnu 
aktivnost na ćelijskim linijama mišjeg karcinoma kolona 
i melanoma i slabiju aktivnost na mMSC u poređenju sa 
efektom cisplatine.
Ključne reči: n- propil polisulfidi, ćelijske linije tumo-
ra, citotoksičnost, in vitro
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INTRODUCTION
Copper is an essential trace element for most living or-
ganisms. It serves as a structural and catalytic cofactor for 
enzymes that play crucial roles in various biochemical pro-
cesses (1). Copper is a cofactor in redox enzymatic reactions 
required for the normal growth and development of organ-
isms. Since copper has roles in many enzymatic reactions (1, 
2), its requirement in different aspects of cancer progression, 
such as immortalization, angiogenesis, and metastasis, is clear 
(3, 4). Copper can induce angiogenesis by directly binding to 
pro-angiogenic factors (such as VEGF) and by stimulating 
the migration of endothelial cells (5). It also triggers prolifera-
tive and metabolic enzymes that increase the ability of cancer 
cells to metastasize (3). Reduced or elevated levels of copper 
have been connected to various pathological conditions in 
humans. Many tumours tend to accumulate high concentra-
tions of copper; the concentrations of copper in serum and 
tumour tissue are significantly higher in cancer patients than 
in healthy subjects, and the copper concentration correlates 
with cancer progression and therapeutic response (6, 7). High 
levels of copper have been found in a wide spectrum of hu-
man cancers, including breast, prostate, colon, lung, and brain 
cancer (6, 8-10). Furthermore, in comparison with normal tis-
sues, tumours have a greater demand for copper and are more 
sensitive to reductions in systemic copper levels (11). 
Antiangiogenic activities of copper-chelating drugs have 
been reported in animal models (11) (12). Another study 
reported impaired oxidative phosphorylation and tumour 
growth after pharmacological suppression of systemic cop-
per, without concomitant effects on tumour angiogenesis 
(13). It has also been shown that copper chelation inhibits 
epithelial-to-mesenchymal transition and decreases the 
expression of vimentin and fibronectin, thus inhibiting the 
migratory and invasive properties of cells (14). Organosul-
fur compounds (diallyl sulfide, DAS; diallyl disulfide, DADS; 
S-ethylcysteine, SEC; N-acetylcysteine, NAC) derived from 
garlic exhibit marked copper-chelating activity (15). 
Here, we analysed the potential antitumour activity of 
the mixture of fifteen n-propyl polysulfides against several 
murine tumour cell lines, including the colon carcinoma 
(CT26), mammary carcinoma (4T1) and melanoma cell 
lines (B16F10), and compared these effects with its anti-
proliferative activity against highly proliferative murine 
mesenchymal stem cells (mMSCs). 
We show that the n-propyl polysulfide mixture exerts 
highly cytotoxic activity against murine colon carcinoma 
and melanoma cell lines, while its antiproliferative activity 
against mMSCs is significantly weaker than that of cisplatin. 
MATERIALS AND METHODS
Preparation of drug solutions
The oil mixture of n-propyl polysulfides (100%) and 10 
mM cisplatin water solution were diluted in cell culture 
medium immediately before use. MTT, 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrazolium bromide, was dis-
solved (5 mg/mL) in phosphate-buffered saline with a pH 
of 7.2, and the solution was filtered through a 0.22 mm 
Millipore filter before use. All reagents were purchased 
from Sigma Chemicals.
Cell culture
CT26, 4T1, and B16F10 cells were purchased from 
American Type Culture Collection (ATCC, Manassas, 
USA). Mouse bone marrow-derived MSCs were purchased 
from Gibco. Cells were maintained in DMEM (Sigma Al-
drich, Munich, Germany) supplemented with 10% foetal 
bovine serum (FBS, Sigma Aldrich, Munich, Germany), 
penicillin (100 IU/mL), and streptomycin (100 μg/mL) in 
a humidified atmosphere of 95% air and 5% CO2 at 37°C. 
Subconfluent monolayers in the log growth phase were 
harvested by a brief treatment with 0.25% trypsin and 
0.02% EDTA in phosphate-buffered saline (PBS, Sigma Al-
drich, Munich, Germany), and the cells were washed three 
times in serum-free PBS. The number of viable cells was 
determined by trypan blue exclusion.
Cytotoxicity assay
The effects of the tested compounds on cell viability 
were determined using the MTT colorimetric technique. 
All examined cells were diluted with growth medium 
to 5x104 cells/ml, and aliquots (5x103 cells/100 ml) were 
placed in individual wells in 96-well plates. The next day, 
the medium was exchanged with 100 μL of test compound, 
which had been serially diluted 2-fold in growth medium 
to concentrations ranging from 1 mg/ml to 0.008 mg/ml. 
Both the n-propyl polysulfide mixture and cisplatin were 
tested in triplicate. Cells were incubated at 37°C and 5% 
CO2 for 24 h. After incubation, the supernatant was re-
moved, and 15% MTT solution (5 mg/mL in PBS, 10 μL) 
in DMEM without FBS was added to each well. After an 
additional 4 h of incubation at 37°C in 5% CO2, the me-
dium with MTT was removed, and DMSO (150 μL) with 
glycine buffer (20 μL) was added to dissolve the crystals. 
The optical density of each well was determined at 595 nm 
using a Zenyth 3100 Multimode microplate detector. The 
percentage cytotoxicity was calculated using the formula: 
% cytotoxicity = 100-((E-B)/(S-B)*100), where B is the 
background optical density of medium alone, S is the total 
viability/spontaneous death of untreated target cells, and E 
is the experimental well. Each of the tested complexes was 
evaluated for cytotoxicity in three separate experiments.
Apoptosis assay
For the detection of apoptosis, CT26 and 4T1 cells 
were plated in T25 culture flasks and allowed to grow 
overnight. After the cells reached subconfluency, the me-
dium was replaced with the test substances (0.01 mg/ml). 
Treated cells were placed at 37°C in a 5% CO2 incubator for 
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24 h. The cultured cells were washed twice with PBS and 
resuspended in 1X binding buffer (10X binding buffer: 0.1 
M Hepes/NaOH (pH 7.4), 1.4 M NaCl, 25 mM CaCl2) at 
a concentration 1x106/mL. Annexin FITC and propidium 
iodide (PI) were added to 100 mL of cell suspension, which 
was then incubated for 15 min at room temperature (25°C) 
in the dark. After incubation, 400 mL of 1X binding buffer 
was added to each tube, and the stained cells were analysed 
within 1 h using a FACS Calibur (BD, San Jose, USA) and 
Flow Jo software (Tri Star). Since Annexin V FITC staining 
precedes the loss of membrane integrity that accompanies 
the later stage identified by PI, an Annexin FITC-positive, 
PI-negative staining pattern indicates early apoptosis, 
while viable cells are Annexin V FITC negative and PI neg-
ative. Cells that are in late apoptosis or are already dead are 
positive for both Annexin V FITC and PI.
RESULTS
Anticancer activity of copper complexes
The results of the MTT assays indicate that the stan-
dardized mixture of n-propyl polysulfides has a strong, 
dose-dependent cytotoxic effect on all three of the tested 
carcinoma cell lines (CT26, 4T1, B16F10) (Figure 1). The 
n-propyl polysulfide mixture had almost the same cytotox-
ic activity as cisplatin against the 4T1 murine mammary 
carcinoma cell line. Interestingly, the cytotoxic effects of 
the n-propyl polysulfide mixture against the murine colon 
cancer and melanoma cell lines (CT26 and B16F10, respec-
tively) were much stronger than those of cisplatin (Figure 
1). Significant cytotoxic effects of the n-propyl polysulfide 
mixture against CT26 and B16 F10 cells were detected at 
even the lowest tested concentration (0.008 mg/ml). Im-
portantly, compared with cisplatin, the tested mixture had 
significantly lower cytotoxicity against mMSCs, which are 
non-cancerous and highly proliferative cells (Figure 1). 
The similar effects of the tested mixture and cisplatin on 
4T1 cells and the significantly greater effects of the mix-
ture against CT26 and B16F10 cells, as well as the lower 
cytotoxicity against mMSCs, were confirmed by analysis 
of the IC50 values (Table 1). 
To determine the possible mode of death of the cells 
treated with the n-propyl polysulfide mixture, flow cy-
tometry analysis of CT26 and 4T1 cells stained with An-
nexin V and PI after exposure to the test mixture (at a 
Table 1. IC50 values (in mM) for 4T1, CT26, and B16F10 cells, as well as 
mMSCs, after exposure to DPPS and cisplatin for 24 h as determined by 
MTT assays. Th e data are presented as the mean ± SD (standard devia-
tion) from three experiments.
IC50 (mg/ml)
Com-
pound
mMSCB16F10CT264T1
0.059±0.0020.023±0.0020.024±0.0180.043±0.006DPPS
0.028±0.0060.123±0.0820.160±0.0920.029±0.004Cisplatin
Figure 1. Graphs presenting the survival of CT26, B16F10, and 4T1 cells, as well as MSCs, after 24 h of growth in the presence of DPPS and cisplatin. 
Data are presented as the mean of three independent experiments.
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concentration of 0.01 mg/ml) for 24 h was performed. In 
agreement with the results of the MTT assays, a stron-
ger cytotoxic effect of the n-propyl polysulfide mixture 
than of cisplatin, as determined by Annexin V PI staining, 
was observed in CT26 cells, while better cytotoxicity in 
4T1 cells was shown for cisplatin (Figure 2). Furthermore, 
analysis of the percentages of stained CT26 and 4T1 cells 
after treatment with the test mixture and cisplatin indi-
cated that apoptosis is not the dominant mechanism of 
cell death induced by the n-propyl polysulfide mixture. 
The percentage of PI+ cells (Annexin V+ PI+ and An-
nexin V- Pi+) was higher in the populations of both CT26 
and 4T1 cells treated with the test mixture than in those 
treated with cisplatin (Figure 2).
DISCUSSION
This study shows for the first time a greater cytotoxic 
effect of an n-propyl polysulfide mixture compared with 
a standard chemotherapeutic agent (cisplatin) in murine 
colon carcinoma (CT26), melanoma (B16F10), and mam-
mary carcinoma (4T1) cell lines. 
The biological activities of various organosulfur 
compounds are partially the result of their chelating ac-
tivity (16). Metal cations, including Cu+ and Cu2+, may be 
involved in the formation of chelating complexes (17). 
Four organosulfur compounds (diallyl sulfide (DAS), 
diallyl disulfide (DADS), S-ethylcysteine, and N-acetyl-
cysteine) show marked copper-chelating capability. The 
method used to determine the chelating effects of DAS 
and DADS on copper is based on restoring the activity 
of xanthine oxidase, which is inhibited in the presence 
of copper (15). 
Our finding that a mixture of n-propyl polysulfides, 
which may have chelating activities, reduces the viability 
of tumour cells agrees with previous findings. The copper 
chelating agent trientine supresses tumour development 
(18, 19). Curcumin, a polyphenol that belongs to the ginger 
family, chelates copper with high affinity and inhibits cell 
proliferation, invasion, metastasis, and angiogenesis (20). 
Administration of curcumin in animal tumour models 
resulted in the suppression of tumour growth associated 
with reduced copper concentrations in the serum of the 
treated groups (20). Furthermore, organic copper-binding 
compounds, such as clioquinol and pyrrolidine dithiocar-
bamate, bind copper and form new complexes that func-
tion as cancer-specific proteasome inhibitors and apopto-
sis inducers in human breast cancer cells (21). 
More than 95% of the total copper in human plasma 
is associated with ceruloplasmin, while the remaining 
plasma copper is associated with albumin and transcu-
prein (22). It has been shown that the concentration of 
ceruloplasmin and transcuprein in tumour tissue is in-
creased. Furthermore, tumour tissue can take up cop-
per from the ceruloplasmin fraction of the plasma (22). 
Copper enters the cell through various transporter 
molecules in the plasma membrane, known as copper 
Figure 2. Representative fl ow plots showing the percentages of early- and late apoptotic and viable CT26 and 4T1 cells after 24 h of treatment with 
DPPS (0.01 mg/ml).
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transporter protein 1 CTR1 (23), and binds to different 
factors, such as metallothionein, cytochrome oxidase, 
superoxide dismutase and the cytosolic copper chap-
erones Cox17 and Atox1 (24). Inhibitors of the copper 
trafficking proteins Atox1 and CCS significantly re-
duce the proliferation of cancer cells with no effects 
on normal cells. Blocking copper trafficking induces 
cellular oxidative stress and reduces the cellular levels 
of ATP (25).
Our findings indicate that the reduction in the viabil-
ity of murine MSCs (noncancerous and highly prolifera-
tive cells) in response to the n-propyl polysulfide mixture 
was smaller than that in response to cisplatin (Figure 1). 
This finding agrees with previous reports that copper 
chelating agents selectively kill human colon cancer cells 
without affecting the viability of noncancerous colon or 
intestinal cells (26). The selective cytotoxic activity of the 
n-propyl polysulfide mixture towards tumour cells may 
be the consequence of more pronounced chelating activ-
ity in tumour cells, as they contain higher amounts of 
copper. The higher percentage of necrotic tumour cells 
exposed to the n-propyl polysulfide mixture is in line 
with a previous finding that the organosulfur compound 
diallyl disulfide induces mainly necrotic death in Can-
dida albicans (27).
Based on our findings, further studies should be done 
to explore the mechanisms of the antitumour action of this 
n-propyl polysulfide mixture, to elucidate the basis of the 
selective activity towards tumour cells and to evaluate for 
in vivo effects in animal tumour models. 
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